Skip to Main Content

Paper Details

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).
Ann Oncol
282
2018
Author NameAffiliation
Ludmila DanilovaThe Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM
Ludmila DanilovaThe Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM
Victor E VelculescuThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University SOM, USA The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy
  • 1 - 3

Datasets

Release 1.2